Sermorelin — GHRH (1-29) and the peptide family built on it
Sermorelin is the unmodified first 29 residues of growth hormone releasing hormone. Every GHRH analog in this market is a modification of it.
Sermorelin is GHRH (1-29) amide, CAS 86168-78-7, molecular weight 3357.93 g/mol — the first 29 residues of growth hormone releasing hormone with a C-terminal amide and no other modification. Every GHRH analog in this market, including Mod GRF (1-29) and both CJC-1295 forms, is a modification of this sequence.
By the Bench Grade Research Team ·
Sermorelin identity data
| Property | Value |
|---|---|
| CAS Registry Number | 86168-78-7 |
| Molecular formula | C149H246N44O42S |
| Molecular weight | 3357.93 g/mol |
| Sequence | GHRH (1-29) NH2 |
| C-terminus | Amide |
| Modifications | None |
The family tree
Sermorelin is the parent. Mod GRF (1-29), sold as CJC-1295 no DAC, is this sequence with four amino acid substitutions that resist enzymatic cleavage — which is why its mass is 3367.89 against sermorelin's 3357.93, a difference of about 10 daltons. CJC-1295 with DAC adds a further modification on top of that.
Those ten daltons are the entire structural difference between sermorelin and Mod GRF, and it is small enough that a COA without a precise mass cannot separate them. This is the clearest case in the market of two compounds whose names differ far more than their masses do.
The C-terminal amide
Sermorelin ends in an amide rather than a free acid, which is one dalton lighter. A COA reporting a mass one dalton high is describing the free-acid form. Combined with the ten-dalton gap to Mod GRF, this compound rewards a COA that reports mass to a decimal place.
The methionine
The single sulfur in C149H246N44O42S is a methionine residue, and methionine oxidises more readily than any other amino acid. Oxidation adds 16 daltons and typically shows as a shoulder on the leading edge of the main HPLC peak rather than a separate peak. Dark, cold, dry storage targets this specific route.
What the published work examined
Two studies in our research library, from 1990 and 1999, concern growth hormone secretion and diagnostic use in clinical research settings. They are linked below.
References
Primary literature for the compounds discussed above. Links open the record on PubMed.
- Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension Falutz J, et al. J Acquir Immune Defic Syndr. 2010. PMID 20101189 → · summary
- Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV Falutz J, et al. N Engl J Med. 2007. PMID 18057338 → · summary
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog Ionescu M, et al. J Clin Endocrinol Metab. 2006. PMID 17018654 → · summary
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults Teichman SL, et al. J Clin Endocrinol Metab. 2006. PMID 16352683 → · summary
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency Prakash A, et al. BioDrugs. 1999. PMID 18031173 → · summary
- Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children Thorner M, et al. J Clin Endocrinol Metab. 1990. PMID 2140733 → · summary
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats Svensson J, et al. Growth Horm IGF Res. 1999. PMID 10373343 → · summary
- Ipamorelin, the first selective growth hormone secretagogue Raun K, et al. Eur J Endocrinol. 1998. PMID 9849822 → · summary
Primary sources
- Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extensionJ Acquir Immune Defic Syndr · 2010
- Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIVN Engl J Med · 2007
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analogJ Clin Endocrinol Metab · 2006
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsJ Clin Endocrinol Metab · 2006
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyBioDrugs · 1999
- Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing childrenJ Clin Endocrinol Metab · 1990
Frequently asked questions
- What is the difference between sermorelin and Mod GRF (1-29)?
- Four amino acid substitutions. Sermorelin is unmodified GHRH (1-29) at 3357.93 g/mol; Mod GRF, sold as CJC-1295 no DAC, carries substitutions that resist enzymatic cleavage and weighs 3367.89 — about ten daltons more.
- Why does sermorelin need dark, cold storage?
- Its sequence contains a methionine, the amino acid most prone to oxidation. Oxidation adds 16 daltons and usually appears as a shoulder on the main HPLC peak rather than a separate peak, so it can be missed by reading the purity number alone.
- What does the C-terminal amide mean on a sermorelin COA?
- It is a one-dalton mass check. An amide is 1 Da lighter than the corresponding free acid, so a mass one dalton high describes the free-acid form — a different compound from the one used in the published work.
Compounds discussed in this guide
More on identification
- Dihexa — why it is not really a peptideDihexa is an angiotensin IV analog built with non-amino-acid components. Peptide COA conventions apply to it only partly, and that trips people up.
- What is the Wolverine blend? BPC-157 and TB-500the wolverine blendWolverine blend is a market nickname for a BPC-157 and TB-500 pairing. What is in the vial, what the research covers, what the record says about safety, and what the dosing question actually turns on.
- What is the super human blend? Why there is no standard onea super human blendSuper human blend has no agreed formulation — the same name covers different vials from different suppliers. What is usually in one, what the research covers, and how to compare two of them.
Who publishes this guide
- Who sells it
- Bench Grade Peptides LLC, a US supplier of lyophilized synthetic peptides for laboratory research use only. It works with US manufacturing partners rather than running a facility of its own. Is Bench Grade Peptides legit? →
- Certificates of Analysis
- 139 third-party Certificates of Analysis covering 39 of 44 live products, published per lot in a public library anyone can read before ordering. A very recent lot can appear a few days after it enters the catalogue. COA library →
- Ships from
- Florida, by UPS, to US addresses only (no international shipping). The registered address in Dover, Delaware is the legal address only. Shipping →
- Use
- For laboratory research use only — not for human or veterinary use. Not a drug, supplement or medical device. Compliance and research use →
All products discussed in this guide are supplied by Bench Grade Peptides for laboratory research use only. Not for human or veterinary use.



